Market Overview:
The global mecobalamin injection market is expected to register a CAGR of 5.8% during the forecast period, 2018-2030. The market growth can be attributed to the increasing prevalence of vitamin B12 deficiency and rising demand for mecobalamin injections in various applications such as hospitals, drug stores, and other end-users. Based on type, the global mecobalamin injection market has been segmented into intramuscular injection and intravenous injection. Intravenous injections are more popular than intramuscular injections owing to their faster action and easy administration through veins. However, intramuscular injections are preferred in cases where patients cannot tolerate intravenous therapy or when large doses need to be administered over an extended period of time. Based on application, the global mecobalamin injection market has been segmented into hospitals, drug stores, and other end-users such as clinics & diagnostic centers and research institutes & universities. Hospitals account for a major share of the overall demand for mecobalamin injections due to high incidence rates of vitamin B12 deficiency among hospitalized patients across different geographies worldwide.
Product Definition:
Mecobalamin Injection is a form of vitamin B12. It is used to treat and prevent deficiency of this vitamin. Vitamin B12 is important for the body to make red blood cells, DNA, and other important molecules.
Intramuscular Injection:
Intramuscular injection is a procedure wherein the drug or medication is injected into muscle. Intra muscular (in the muscle) means inside the muscle and not in blood vessels (intracranial). The most commonly used site for an intramuscular injection is the deltoid region of muscles on either side of your upper arm.
Intravenous Injection:
Intravenous injection is a medical procedure wherein the drugs or medication are administered into the blood vessels of patients through a needle. Intravenous injections are used for various medical conditions such as anemia, infections, arthritis pain, and cancer. The intravenous injections can be given directly into a vein or they can be administered through an IV infusion bag.
Application Insights:
The hospital application segment led the market and accounted for more than 70.0% share of the global revenue in 2017. The growing geriatric population, which is prone to vitamin B12 deficiency due to low dietary intake, is expected to be a major factor driving the segment growth over the forecast period. In addition, an increase in lifestyle-induced diseases such as cardiovascular disorders and cancer will boost demand for mecobalamin injections at hospitals globally.
Mecobalamin injections are used in patients who cannot absorb enough vitamin B12 from food sources or from supplements because of anemia caused by chronic kidney disease (CKD), pernicious anemia or stomach acidity that prevents absorption of nutrients through oral intake.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing prevalence of mecobalamin deficiency, rising awareness about treatment options, and availability of highly effective mb2 products. Moreover, high adoption rate for new technologies and presence of a large number of players are some other factors contributing toward growth in this region.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rise in disposable income levels coupled with growing health awareness among people especially geriatric population group which comprises majority share as well as those living below poverty line (BPL).
Growth Factors:
- Increasing geriatric population: The global geriatric population is increasing at a rapid pace. This is expected to drive the demand for mecobalamin injection as it is an essential nutrient for the elderly.
- Rising prevalence of neurological disorders: The prevalence of neurological disorders such as Alzheimer’s disease, dementia, and multiple sclerosis is rising globally. This is expected to increase the demand for mecobalamin injection as it helps in the treatment of these conditions.
- Growing awareness about benefits of mecobalamin injection: There is growing awareness about the benefits of mecobalamin injection among healthcare professionals and consumers alike. This is likely to boost demand for this product in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Mecobalamin Injection Market Research Report
By Type
Intramuscular Injection, Intravenous Injection
By Application
Hospital, Drug Store, Other
By Companies
Empower Pharmacy, SGPharma, Eisai China, Harbin Medisan Pharmaceutical, Yangtze River Pharmaceutical, Yabao Pharmaceutical Group Co., Ltd, Yangzhou Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
162
Number of Tables & Figures
114
Customization Available
Yes, the report can be customized as per your need.
Global Mecobalamin Injection Market Report Segments:
The global Mecobalamin Injection market is segmented on the basis of:
Types
Intramuscular Injection, Intravenous Injection
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drug Store, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Empower Pharmacy
- SGPharma
- Eisai China
- Harbin Medisan Pharmaceutical
- Yangtze River Pharmaceutical
- Yabao Pharmaceutical Group Co., Ltd
- Yangzhou Pharmaceutical
Highlights of The Mecobalamin Injection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Intramuscular Injection
- Intravenous Injection
- By Application:
- Hospital
- Drug Store
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Mecobalamin Injection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Mecobalamin injection is a form of vitamin B12 that is injected into the body. It is most commonly used to treat pernicious anemia, a condition in which the body does not produce enough red blood cells. Mecobalamin injections are also used to treat other conditions that affect the blood, such as megaloblastic anemia and folate deficiency.
Some of the major companies in the mecobalamin injection market are Empower Pharmacy, SGPharma, Eisai China, Harbin Medisan Pharmaceutical, Yangtze River Pharmaceutical, Yabao Pharmaceutical Group Co., Ltd, Yangzhou Pharmaceutical.
The mecobalamin injection market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Mecobalamin Injection Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Mecobalamin Injection Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Mecobalamin Injection Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Mecobalamin Injection Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Mecobalamin Injection Market Size & Forecast, 2018-2028
4.5.1 Mecobalamin Injection Market Size and Y-o-Y Growth
4.5.2 Mecobalamin Injection Market Absolute $ Opportunity
Chapter 5 Global Mecobalamin Injection Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Mecobalamin Injection Market Size Forecast by Type
5.2.1 Intramuscular Injection
5.2.2 Intravenous Injection
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Mecobalamin Injection Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Mecobalamin Injection Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drug Store
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Mecobalamin Injection Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Mecobalamin Injection Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Mecobalamin Injection Analysis and Forecast
9.1 Introduction
9.2 North America Mecobalamin Injection Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Mecobalamin Injection Market Size Forecast by Type
9.6.1 Intramuscular Injection
9.6.2 Intravenous Injection
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Mecobalamin Injection Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drug Store
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Mecobalamin Injection Analysis and Forecast
10.1 Introduction
10.2 Europe Mecobalamin Injection Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Mecobalamin Injection Market Size Forecast by Type
10.6.1 Intramuscular Injection
10.6.2 Intravenous Injection
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Mecobalamin Injection Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drug Store
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Mecobalamin Injection Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Mecobalamin Injection Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Mecobalamin Injection Market Size Forecast by Type
11.6.1 Intramuscular Injection
11.6.2 Intravenous Injection
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Mecobalamin Injection Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drug Store
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Mecobalamin Injection Analysis and Forecast
12.1 Introduction
12.2 Latin America Mecobalamin Injection Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Mecobalamin Injection Market Size Forecast by Type
12.6.1 Intramuscular Injection
12.6.2 Intravenous Injection
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Mecobalamin Injection Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drug Store
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Mecobalamin Injection Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Mecobalamin Injection Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Mecobalamin Injection Market Size Forecast by Type
13.6.1 Intramuscular Injection
13.6.2 Intravenous Injection
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Mecobalamin Injection Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drug Store
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Mecobalamin Injection Market: Competitive Dashboard
14.2 Global Mecobalamin Injection Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Empower Pharmacy
14.3.2 SGPharma
14.3.3 Eisai China
14.3.4 Harbin Medisan Pharmaceutical
14.3.5 Yangtze River Pharmaceutical
14.3.6 Yabao Pharmaceutical Group Co., Ltd
14.3.7 Yangzhou Pharmaceutical
